
Join to view full profile
55 Fruit StYawkey 9aBoston, MA 02114
Phone+1 617-643-4269
Fax+1 617-724-1079
Dr. Browne is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1982 - 1985
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1979 - 1982
Georgetown University School of MedicineClass of 1979
Certifications & Licensure
MA State Medical License 1980 - 2028
NH State Medical License 2008 - 2020
RI State Medical License 1988 - 1996
MD State Medical License 1984 - 1988
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Partners Longitudinal Medical Record, Partners Healthcare System, 2012, 2014-2015, 2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2015, 2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2015, 2017
Clinical Trials
Publications & Presentations
PubMed
- 6 citationsPhase II study of 5-fluoruracil leucovorin and azidothymidine in patients with metastatic colorectal cancerJeffrey Clark, William M. Sikov, Frank J. Cummings, Marcia J. Browne, Wallace Akerley
Journal of Cancer Research and Clinical Oncology. 1996-01-01 - 5 citationsPhase I Trial of High-Dose Infused Zidovudine Combined with Leucovorin plus FluorouracilJulie Beitz, James W. Damowski, Frank J. Cummings, Marcia J. Browne, Jeffrey Clark
Cancer Investigation. 1995-01-01 - 17 citationsCombined modality therapy for stage IIIA non-small cell carcinoma of the lung.Alan B. Weitberg, John Yashar, Arvin S. Glicksman, Marshall R. Posner, Frank J. Cummings
European Journal of Cancer. 1993-01-01
Press Mentions
Mass General Cancer Center’s Women Leaders in Oncology: Women’s History Month Q&AMarch 28th, 2023
Exploring Opportunities to Expand Cancer CareMay 16th, 2014
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: